Почетна › Рак на дојка › Њујорк
Клинички испитувања за Рак на дојка во Њујорк
176 студии за Рак на дојка бараат учесници на локации во Њујорк.
Градови во Њујорк
- New York City136 студии
- Queens64 студии
- Greenburgh42 студии
- Staten Island40 студии
- New Rochelle38 студии
- The Bronx17 студии
- Buffalo16 студии
- Rochester15 студии
- Brooklyn11 студии
- Yonkers6 студии
- Queensbury5 студии
- Syracuse5 студии
- Manhattan4 студии
- Albany4 студии
- Shirley3 студии
Официјален текст на студијата (англиски)
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, New York
- Research Site, New York
Се регрутираФаза 1/2
Возраст од 18 до 130 · Сите полови · Ажурирано 5.10.2026 · NCT05417594Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06982521Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Kings County Hopsital Center, Brooklyn
- Queens Cancer Center of Queens Hospital, Jamaica
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
- и уште 1
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04751435A Study of Mental Health Care in People With Cancer
- Memorial Sloan Kettering Cancer Center, New York
Се регрутира
Возраст 65 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06037954Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06784193A Study of PHST001 in Advanced Solid Tumors
- START Center for Cancer Research - Long Island New York, Lake Success
- Mount Sinai, New York
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06840886A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и уште 1
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT05534438Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
- Roswell Park Cancer Institute, Buffalo
Се регрутираДобредојдени се здрави волонтери
Возраст 18 и постари · Жени · Ажурирано 2.10.2026 · NCT03897270The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Queens Cancer Center of Queens Hospital, Jamaica
- Optum Health, Lake Success
- Mount Sinai School of Medicine, New York
Се регрутираФаза 3
Возраст од 18 до 100 · Сите полови · Ажурирано 2.10.2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Research Site, New York
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07205822A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Hematology Oncology Associates of Central New York, Camillus
- Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07102381A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute IDS, Buffalo
- Memorial Sloan Kettering Hospital, New York
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06172478A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07701941Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- Roswell Park Comprehensive Cancer Center, Buffalo
Се регрутираФаза 2
Возраст 70 и постари · Сите полови · Ажурирано 1.10.2026 · NCT04305834A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- University of Rochester Medical Center, Rochester
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06369285Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06625775Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Memorial Sloan-Kettering Cancer Center, New York
- New York Cancer & Blood Specialists, Shirley
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT06324357A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и уште 1
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07218250Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- New York Proton Center, New York
Се регрутираФаза 2
Возраст 50 и постари · Жени · Ажурирано 29.9.2026 · NCT01766297A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New York
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05877599Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- New York Proton Center, New York
Се регрутираФаза 3
Возраст 19 и постари · Жени · Ажурирано 29.9.2026 · NCT05856773Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Mineola
- Avenzo Therapeutics Recruiting Site, New York
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05867251A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Queens Hospital Cancer Center ( Site 0011), Jamaica
- Optum Medical Care, PC ( Site 0009), Westbury
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07060807A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- NYU Langone Health - Brooklyn ( Site 0089), Brooklyn
- NYU Langone Hospital - Long Island ( Site 0090), Mineola
- Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
- и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06312176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, New York
- Research Site, Stony Brook
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07007559A Study of Language Interpretation Solutions for People With Breast Cancer
- Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
- и уште 2
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06721065A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- и уште 1
Се регрутираФаза 1
Возраст 18 и постари · Жени · Ажурирано 24.9.2026 · NCT05412225Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- New York Cancer and Blood Specialists, Babylon
- NYU Langone Health, New York
- University of Rochester (URMC), Rochester
- и уште 1
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07214532Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, New York
- Clinical Trial Site, New York
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07085767A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07114601Intra-Operative Radiation Registry
- Montefiore Medical Center - Moses Campus, The Bronx
Се регрутираНабљудувачка студија
Возраст 18 и постари · Жени · Ажурирано 22.9.2026 · NCT04994067A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213791A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- NYOH Albany Cancer Center, Albany
- New York University (NYU) Brooklyn, Brooklyn
- Memorial Sloan Kettering Cancer Center, New York
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07174336A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- Memorial Sloan Kettering Cancer Center, New York
- Wilmot Cancer Institute, Rochester
- New York Cancer and Blood Specialists, Shirley
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 22.9.2026 · NCT07287098Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- Weill Cornell Medicine, New York
Се регрутираДобредојдени се здрави волонтери
Возраст од 30 до 74 · Жени · Ажурирано 21.9.2026 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- и уште 1
Се регрутираФаза 2
Возраст 45 и постари · Жени · Ажурирано 21.9.2026 · NCT04084730A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Memorial Sloan Kettering Cancer Center Westchester, Harrison
- Beth Israel Comprehensive Cancer Center, New York
- Mount Sinai Medical Center, New York
- и уште 5
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06827236Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.